Home
Live Updates
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says : comparemela.com
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says
Gerresheimer CEO Dietmar
Siemssen said he expects about 4% of the company's revenue
growth per year from deals to supply makers of drugs for weight
loss and diabetes with vials, cartridges, syringes...
Related Keywords
Mexico ,
China ,
Czech Republic ,
United States ,
Germany ,
Brazil ,
American ,
America ,
German ,
Mexican ,
Schott Pharma ,
Eli Lilly ,
Dietmar Siemssen ,
Reuters ,
Novo Nordisk ,
North American ,
South America ,
South American ,
West Pharmaceuticals ,
Patrick Wingrove Editing ,
Bill Berkrot ,
Markets ,
comparemela.com © 2020. All Rights Reserved.